Proceedings of the Think Tank for Osteosarcoma Medical Advisory Board

By sjmartinez • June 27, 2024

Chawla SP, VAN Tine B, Federman N, Schwab J, Jones R, Subbiah V, Chawla NS, Afshar N, Hoos W, Feldman N, Spencer HT, Swaney W, Gordon EM. Proceedings of the Think Tank for Osteosarcoma Medical Advisory Board. Anticancer Res. 2024 Jul;44(7):2765-2768. doi: 10.21873/anticanres.17139. PMID: 38925853.

Tags: cancer stem cell, CAR-T cell therapy, DeltaRex-G, Gene therapy, Hematology/Oncology, immunotherapy, osteosarcoma, personalized medicine, Publications, repurposed drugs, review

Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal study

Duivon M, Christy F, Thomas E, Lequesne J, Castel H, Gaudin C, Delmas D, Boyault S, Rigal O, Bousrih C, Lévy C, Lerebours F, Di[...]

Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer. Reply

Bardia A, Schwaederle M, Curigliano G. Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer. Reply. N Engl J Med. 2025 Feb 20;392(8):830-831. doi:[...]

Frailty: Can a Biological Aging Marker Enhance Precision Risk Assessment of Cancer Therapy Cardiotoxicity?

Sedrak MS, Asnani A. Frailty: Can a Biological Aging Marker Enhance Precision Risk Assessment of Cancer Therapy Cardiotoxicity? JACC CardioOncol. 2025 Feb;7(2):122-124. doi: 10.1016/j.jaccao.2025.01.004. PMID:[...]